Mouse studies have been instrumental in forming our current understanding of early cell-lineage decisions; however, similar insights into the early human development are severely limited. Here, we present a comprehensive transcriptional map of human embryo development, including the sequenced transcriptomes of 1,529 individual cells from 88 human preimplantation embryos. These data show that cells undergo an intermediate state of co-expression of lineage-specific genes, followed by a concurrent establishment of the trophectoderm, epiblast, and primitive endoderm lineages, which coincide with blastocyst formation. Female cells of all three lineages achieve dosage compensation of X chromosome RNA levels prior to implantation. However, in contrast to the mouse, XIST is transcribed from both alleles throughout the progression of this expression dampening, and X chromosome genes maintain biallelic expression while dosage compensation proceeds. We envision broad utility of this transcriptional atlas in future studies on human development as well as in stem cell research.
In Brief
A comprehensive transcriptional map of human preimplantation development reveals a concurrent establishment of trophectoderm, epiblast, and primitive endoderm lineages and unique features of X chromosome dosage compensation in human.
SUMMARY
Mouse studies have been instrumental in forming our current understanding of early cell-lineage decisions; however, similar insights into the early human development are severely limited. Here, we present a comprehensive transcriptional map of human embryo development, including the sequenced transcriptomes of 1,529 individual cells from 88 human preimplantation embryos. These data show that cells undergo an intermediate state of co-expression of lineage-specific genes, followed by a concurrent establishment of the trophectoderm, epiblast, and primitive endoderm lineages, which coincide with blastocyst formation. Female cells of all three lineages achieve dosage compensation of X chromosome RNA levels prior to implantation. However, in contrast to the mouse, XIST is transcribed from both alleles throughout the progression of this expression dampening, and X chromosome genes maintain biallelic expression while dosage compensation proceeds. We envision broad utility of this transcriptional atlas in future studies on human development as well as in stem cell research.
INTRODUCTION
During the first 7 days of human development, the zygote undergoes cellular division and establishes the first three distinct cell types of the mature blastocyst: trophectoderm (TE), primitive endoderm (PE), and epiblast (EPI) (Cockburn and Rossant, 2010) . Although the molecular control underlying the formation of these lineages has been extensively explored in animal models, our knowledge of this process in the human embryo is rudimentary. In recent years, a limited number of studies have focused on translating conclusions from animal model systems to the human, providing many insights, but also revealing crucial species differences in the transcriptional and spatio-temporal regulation of lineage markers (van den Berg et al., 2011; Blakeley et al., 2015; Kunath et al., 2014; Niakan and Eggan, 2013) , cell signaling responses (Kuijk et al., 2012; Roode et al., 2012; Yamanaka et al., 2010) , as well as X chromosome inactivation (XCI) (Okamoto et al., 2011) , thereby highlighting the need for studies of the human embryo.
In mouse, the TE and the inner cell mass (ICM) segregate first, and this is controlled by the opposing transcription factors caudal type homeobox 2 (CDX2) and POU domain class 5 transcription factor 1 (POU5F1, also known as OCTCT3/4) (Niwa et al., 2005) . Cdx2 is expressed ubiquitously at the 8-cell stage and then restricted to the outer cells of the 16-cell morula and the early 32-cell blastocyst. CDX2 repress POU5F1 expression in these outer cells, driving specification and maturation of the TE and ICM (Niwa et al., 2005) . In the human, however, CDX2 protein is not expressed in the outer cells of the morula, but is only detected in the established blastocyst and coincides with POU5F1 in TE cells; thereby raising questions on the degree of conservation between the mouse and human TE-ICM maturation control mechanisms (van den Berg et al., 2011; Niakan and Eggan, 2013) . Comparative studies on mouse, cattle, and human further suggest that the regulatory elements of Pou5f1 diverged during mammalian evolution (van den Berg et al., 2011) .
Further, it remains unclear when and how the divergence of the ICM into pluripotent EPI and PE occurs in human. Studies using antibody staining for lineage markers, such as NANOG, GATA4/ 6, and SOX17, encircled a rather wide range for this split; either coinciding with the blastocyst formation at embryonic day 5 (E5), or occurring during the late blastocyst stage at E7, just prior to implantation (Kuijk et al., 2012; Niakan and Eggan, 2013; Roode et al., 2012) .
Another elusive facet of early human development is X chromosome dosage compensation. Eutherian mammals achieve X gene dose balance between females (XX) and males (XY) by transcriptional silencing of one X chromosome in female cells (Lyon, 1961) . Failure to accomplish dosage compensation results in embryonic lethality Takagi, 1998, 2000) . In mouse, imprinted inactivation of the paternal X chromosome initiates around the 4-cell stage (Deng et al., 2014a; Heard et al., 2004) and is mediated by cis coating of the silenced X chromosome with the long non-coding RNA (lncRNA) Xist (Clemson et al., 1998) . The paternal X chromosome is thereafter kept inactivated in the TE and PE lineages, while reactivation and a round of random XCI takes place in the pre-and peri-implantation stage epiblast Monk and Harper, 1979; Okamoto et al., 2004; Takagi and Sasaki, 1975) . In contrast to the mouse, XCI is not imprinted in the human placenta (Moreira de Mello et al., 2010) , which is a TE-derived tissue. Furthermore, the prevailing view is that human XCI does not take place until after implantation, or at least beyond the late blastocyst stage (Deng et al., 2014b) , since RNA-FISH on X-linked genes, including XIST, show biallelic expression in most female TE and ICM blastomeres, even as late as E7 (Okamoto et al., 2011) . Still, many aspects of the preimplantation regulation of the human X chromosome remain unexplored, as the available data rely mainly on allelic analyses of a few individual genes and direct assessments of female and male expression levels were previously not feasible.
Using single-cell RNA sequencing (RNA-seq) technology, we now provide a comprehensive resource, characterizing the transcriptional dynamics of progressive lineage specification and reveal X chromosome dosage compensation in the human preimplantation embryo.
RESULTS

Single-Cell RNA-Seq Transcriptome Profiling of Human Preimplantation Embryos
To obtain a transcriptional map of the human preimplantation development, we sequenced the transcriptomes of individual cells isolated from embryos ranging from the 8-cell stage up to the time-point just prior to implantation. After quality control, we retained 1,529 high-quality single-cell transcriptomes from 88 embryos, with an average of 8,500 expressed genes (reads per kilobase of transcript per million mapped reads [RPKM] R1; Spearman's r R0.63; Figure 1A ). A total of 13 to 24 embryos and 81 to 466 cells were analyzed per embryonic day ( Figure 1B) . To determine the sex of each embryo, we assessed the expression level of Y-linked genes for each cell ( Figure S1 ).
To first study the maternal to zygotic transition, we assessed the activity of ubiquitously expressed Y chromosome genes (i.e., genes exclusively derived from the paternal germline) and found an increase between E3 and E4 ( Figure 1C (E) Two-dimensional t-SNE representation of 1,529 single-cell preimplantation transcriptomes using the 500 most variable genes across all cells (according to Figures S2A and S2B ). E3-E7 indicate the embryonic day and E4.late and E5.early indicate cells picked 4-6 hr later and earlier, respectively, than the other cells from that embryonic day.
(F) A pseudo-time was assigned to each cell by fitting a principal curve to the cells in the two-dimensional t-SNE subspace ( Figure 1E ). ICM cells were excluded from the fit to let the principal curve better reflect time and minimize lineage-effects (Supplemental Experimental Procedures of single nucleotide polymorphisms (SNPs) in the single-cell RNAseq reads, we observed that most male E3 cells contained biallelically derived RNA of X chromosome genes ( Figure 1D ), indicating the presence of lingering maternal transcripts. This biallelic signal was devoid in E4 and later stages ( Figures 1D, S1H , and S1I), suggesting that maternal RNA clearance had occurred. Thus, our data point to incomplete zygotic genome activation (ZGA) at E3 that approaches completion by E4, in line with previous studies (Yan et al., 2013) . In order to explore the data in an unbiased manner, we carried out dimensionality reduction using the most variable genes across all cells, accounting for the mean-variance relationship present in single-cell RNA-seq gene expression data (Brennecke et al., 2013) (Figures S2A and S2B ). We found that regardless of dimensionality reduction technique used, the primary segregating factor was developmental time, as cells were clearly ordered in agreement with embryonic day when projected onto the first dimensionality-reduced components ( Figures 1E, S2C , and S2D). To further refine the resolution of the developmental timing of each individual cell, we fitted a principal curve (Hastie and Stuetzle, 1989) to the cells in a t-distributed stochastic neighbor embedding (t-SNE) subspace (van der Maaten and Hinton, 2008) ( Figure 1F ) and assigned a pseudo-time to each cell based on its projection onto this curve, which we utilized in parts of the temporal analysis.
Segregation of ICM and TE Appears at E5
The second strongest segregating factor emerged during E5, where the spread between cells sharply increased, perpendicular to the developmental time axis (Figure 2A ). This coincided with the time of blastocoel formation, indicating that this time period is critical for the formation of a blastocyst and the emergence of lineages. In order to identify lineages, we applied principal component analyses (PCA) and clustering using the most variable genes ( Figure 2B ; Supplemental Experimental Procedures). The separation of cells along principal component 1 (PC1) corresponded to the TE and ICM segregation since the genes with the strongest loadings on PC1 were well-known TE lineage markers (GATA2 and GATA3) as well as known ICM markers (SOX2 and PDGFRA). Importantly, these TE and ICM genes were identified as top-genes using an unbiased datadriven approach, starting with 15,633 expressed genes. The same procedure was then applied to E6 and E7 cells to classify the lineage fate of the cells as ICM or TE ( Figure S3 ). Interestingly, applying the same unbiased approach separately to E3, E4, and to only immature E5 cells (those marked as pre-lineage in Figure 2A ), no groupings of cells were identified. Similarly, we observed no grouping among these cells when using previously known human and mouse markers (Blakeley et al., 2015; Guo et al., 2010; Yan et al., 2013) nor when using lineage-specific genes identified in this study.
Once cells had been designated as TE or ICM, we performed differential expression analysis between the lineages. The differential expression analysis identified 2,414 genes that were significantly differentially expressed between E5 ICM and TE cells (false discovery rate [FDR] %5%); and 2,383 and 3,053 differentially expressed genes in E6 and E7, respectively (Table S1 ). Selecting the top 500 differentially expressed genes, we found that E5 cells (excluding the immature E5 cells) segregated into three groups ( Figure 2C ). Two of these groups distinctly expressed either TE or ICM genes in a mutually-exclusive manner, indicating more matured TE and ICM lineages, whereas the third group of cells co-expressed TE and ICM genes but at a lower expression level. Based on this, we denoted the co-expressing cluster of cells as E5.mid (since these cells seemed uncommitted to a particular lineage) and labeled the other two distinct groups as either TE or ICM and denoted them as E5.late. Further, ICM and TE genes identified at E5 tended to maintain their lineage specificity throughout the remainder of the preimplantation development, as their ICM versus TE fold-changes were consistent from E5 to E7, despite that E6 and E7 lineage assignment was done independently of the E5 gene set (right-hand side bars in Figure 2C ).
Segregation of ICM into EPI and PE Appears among E5 ICM Cells
To identify EPI and PE cells, we performed a similar analysis as described above, using the most variable genes within the ICM Figure 1E , showing ICM and TE assignment of cells. Cells from E5 are highlighted in the lower left insert. The ICM-TE cell classification was done using PAM clustering in a PCA dimensionality-reduced sub-space ( Figure 2B and Supplemental Experimental Procedures). (B) PCA biplot showing ICM and TE classification of cells from E5. Cells were classified as ICM or TE using PAM clustering in the PCA dimensionality-reduced space with the 250 most variable genes across all non-pre-lineage E5 cells as input (Supplemental Experimental Procedures) . Cells in embryos with a pseudotime <12.5 were assigned as pre-lineage. Genes with high PC loadings are shown. Colors indicate the weighted mean of the expression of previously known lineage markers using weights À1 and 1 for ICM and TE genes, respectively. (C) Heatmap of E5 cells and the top 500 differentially expressed genes between ICM and TE E5 cells (top 250 genes from each lineage). Upper colored bar indicates embryo membership, lower bar indicates lineage. Right-hand-side bars indicate the log2 fold-change of the TE divided by ICM mean-expression level for each gene and embryonic day (E5-E7). (D) PCA biplot showing EPI and PE classification of ICM cells from E5. Cells were classified as EPI or PE using PAM clustering in the PCA dimensionality-reduced space with the 250 most variable genes across all ICM cells that belonged to the right-most hierarchical cell-cluster in Figure 2C Figure S3 and Tables S1 and S2 cells for each embryonic day (Figures 2 and S3) . Surprisingly, along the second PC, we found ICM cells as early as E5 separated with respect to EPI and PE lineage-specificity (Figure 2D) . Among the genes with the highest PC loadings were pluripotency-related genes and known EPI markers (SOX2, TDGF1, DPPA5, GDF3, and PRDM14), and among the genes with the most negative PC loadings were genes implicated in endoderm specification (PDGFRA, FGFR2, LAMA4, and HNF1B) . Differential expression analysis between the EPI and PE cells identified 43, 1,412, and 542 differentially expressed genes at E5, E6, and E7, respectively (FDR %5%; Table S1 ). Furthermore, differentially expressed genes found in E5 maintained their EPI and PE specificity in E6 and E7 ( Figure 2E ). The number of cells per lineage and embryonic day resulting from the lineage classification is summarized in Figure 2F .
Lineage-Specific Genes Relate to Cell Fate Functionality To find lineage-specific genes, we combined the Z scores obtained from the differential expression analysis of one lineage against each of the other two (Stouffer's method; FDR %5%; Figure 2F ; Table S1 ). Next, to find genes that maintain their lineage-specificity from E5 to E7, we combined the lineage-specific results across embryonic days, which resulted in 439, 820, and 222 significantly maintained TE-, EPI-, and PE-specific genes, respectively (Stouffer's method; FDR %5%; Figure 2F ; Table  S2 ). The top-ranked maintained EPI genes exhibited expression patterns clearly specific for cells of the EPI lineage in E6 and E7 whereas in E5 the EPI genes were to some extent also expressed in PE cells ( Figures 3A and 3B ). Top-ranked maintained PE genes were specifically expressed across E5 to E7, and TE genes had low expression in E3 and E4 but were expressed in all cells from E5 to E7, although at a higher expression level in TE cells (Figures 3A and 3B) . Several known TE markers, such as GATA3, DAB2, and GATA2 were among the top-ranked genes (rank 2, 25, and 58, respectively). Interestingly, CDX2 was differentially expressed, but only ranked 209 th , and EOMES was not expressed at all. In addition to known markers, several lessdescribed markers were identified, such as PTGES, EMP2, TGFBR3, and PDGFA (rank 1, 4, 23, and 33). Among top-ranked EPI-specific genes were factors implicated in embryonic preimplantation development in mouse or human, such as PRDM14, GDF3, TDGF1, NODAL, SOX2, and NANOG (rank 1, 3, 9, 10, 12, and 22 ) and a few less-established markers, including DPPA5, ESRG, KLF17, ARGFX, and DPPA2 (rank 2, 4, 5, 7, 19) . PE-specific genes included known factors such as COL4A1, HNF1B, PDGFRA, GATA4 and FN1 (rank 3, 4, 7, 13, and 15) and among highly ranked genes were also LINC00261, FRZB, AMOTL1, and DPP4 (rank 1, 5, 6, and 14) . Expression profiles for a subset of the maintained lineage markers are shown for all cells, stratified by embryo, in Figure S3I .
To explore the functional roles of lineage-specific genes, we performed Gene Ontology (GO) gene set enrichment analyses on the top 100 maintained lineage genes from E5 to E7 (Figure 3C ; Table S3 ). EPI-specific genes were enriched for cell fate specification, stem cell maintenance, and embryonic pattern specification. PE-specific genes were enriched for terms such as morphogenesis of an epithelium and endoderm development. TE-specific genes were enriched in apical plasma membrane, cell morphogenesis involved in differentiation, and active transmembrane transporter activity. This is in agreement with the notion that the TE forms an outer layer of cells that acts as a barrier, preventing water and solutes from passing freely through the paracellular space.
Subpopulations within the TE Lineage
To determine whether subpopulations were present within the lineages, we investigated the most variable genes for each lineage and embryonic day (Supplemental Experimental Procedures). Interestingly, we found two sub-clusters of cells among E6 and E7 TE cells ( Figure 3D ), and differential gene expression analysis between the two groups of cells (Kharchenko et al., 2014) identified 269 and 349 significantly differentially expressed genes in E6 and E7, respectively (Table S4) , of which 135 genes overlapped between E6 and E7 (129 upregulated and 6 downregulated). We identified several genes that have been previously associated with trophoblast differentiation ( Figure 3F ), including CCR7 (rank 1) (Drake et al., 2004) , CYP19A1 (rank 4) (Kumar et al., 2013) , DLX5 (rank 5) (Marchand et al., 2011) , ERVFRD-1 (rank 6) (Mi et al., 2000) , GCM1 (rank 7) (Marchand et al., 2011) , GREM2 (rank 8) (Sudheer et al., 2012) , MUC15 (rank 13) (Marchand et al., 2011) , and OVOL1 (rank 16) (Renaud et al., 2015) . At an embryo level, we found that the 129 upregulated genes segregated the cells into two clusters consistent with our classification ( Figure 3E ). These genes were significantly enriched in 38 GO terms, most of which were related to cell-cell signaling including ''molecular transducer activity'' and ''signal transducer activity'' (Table S4 ). The significant terms and genes were consistent with a more differentiated polar subpopulation of the TE cells, relying on cell-cell communication between the (B) Boxplot of mean expression level with respect to top 25 maintained lineage-specific genes, from each lineage, stratified by embryo and lineage. The mean expression across genes was calculated after Z score normalization as to account for that genes can be expressed at different scales. (C) Normalized RPKM mean-expression levels and Gene Ontology gene set enrichment results of top 100 lineage-specific genes from each lineage. The mean expression of each gene was calculated per embryonic day and lineage and Z score normalized across those strata. (D) Heatmap of top variable genes within TE cells, stratified by embryonic day. Cells were clustered by PAM-clustering in the PC1 and PC2 subspace. Genes were ordered by hierarchical clustering. (E) Boxplot of TE cells with respect to their mean expression level using 129 polar TE genes that were significant in both E6 and E7, stratified by embryo and polarmural classification. The mean expression across polar-specific TE genes was calculated after Z score normalization. endometrium and the implanting polar TE of the blastocyst. Moreover, we observed higher levels of CCR7 protein at the polar side of the embryo ( Figure 3G ), in both TE and ICM cells, supporting that the identified TE subpopulations likely reflect polar and mural cells.
Gene Expression-Inferred Developmental Timing
Corroborates Concurrent Lineage Segregation First, to assess temporal differences we conducted differential gene expression analysis between embryonic time points. In almost every contrast there were more than 1,000 significantly differentially expressed ( Figure S4A ). Top genes included DNMT3L (E3 versus E4), TE genes such as CLDN4, CLDN10, GATA2, and SLC2A1 (E4 versus E5.pre-lineage) and CGA and PGF, which were strongly upregulated in all three lineages from E5 to E7 (Table S5) .
To obtain a combined view of the lineage specification and developmental state, we applied diffusion map dimensionality reduction (Haghverdi et al., 2015) on all cells using the lineagespecific genes. This revealed the progressive development from E3 to early E5, followed by a split into three lineages (Figure 4A ; Movie S1). To further elucidate the dynamics of the lineage specification, we scored the degree of ICM or TE segregation of all cells (as the distance to the ICM-TE decision surface) as a function of inferred developmental time (pseudo-time) ( Figure 4B ). This corroborated that the blastocyst forms distinct transcriptional states corresponding to lineages during E5, after which the segregation (based on lineage-specific genes) did not further increase. The analyses also revealed that cells of E3 and E4 embryos were more similar to the ICM than the TE, expressing genes that will later become specific to the ICM. We applied the same analysis with respect to the EPI and PE lineages and again observed a separation occurring during E5, which did not increase over time ( Figure 4C ).
As a complementary approach, we investigated whether individual genes had segregating expression levels before E5. To this end, we calculated a gene expression variability score within each embryo for every gene and regressed it onto embryonic pseudo-time (Supplemental Experimental Procedures). The majority of lineage-specific genes gradually increased in variability and reached their maximum at E5 or later ( Figure S4B ). Furthermore, lineage-specific genes expressed already during E4 ( Figures 4D-4G , described below) also increased in variability at E5 or later, suggesting the existence of a more homogeneous co-expressing state followed by increasingly heterogeneous expression.
Co-expression of Lineage Markers Precedes Matured Lineages
To investigate the transition from morula to blastocyst in more detail, we focused on cells from E3 to E5 and lineage-specific genes (the top 100 differentially expressed genes in each of the three lineages). The TE-specific genes formed three main clusters ( Figures 4D and 4E ), reflecting the order at which their expression became on par with that in mature TE cells (denoted TE.early, TE.mid, and TE.late). Also, the PE-and EPI-specific genes formed two main clusters each, corresponding to the time at which they increased in expression levels (Figures 4D and 4E) . During E4, the cells tended to express early EPI genes, corresponding to about half of the investigated EPI-specific genes and a smaller subset of PE and TE genes. Interestingly, during early E5 the cells had activated about half of the TE genes (TE.early and TE.mid), while still maintaining the expression of early EPI genes, indicative of an intermediate stage of coexpression of lineage markers. Fewer co-expressing cells were observed at E6 and E7, corroborating that this is indeed a cellular state that precedes maturation of the lineages. The expression dynamics of gene set ( Figure 4F ) and individual genes ( Figure 4G ) over embryo stage highlighted that many EPI genes were already turned on in E3 and E4 (e.g., DPPA5, ARGFX, and SOX2), whereas a second group of EPI genes were first turned on in E5.mid, including FGF4, TDGF1, and NODAL.
To extend the gene-dynamics analysis, we calculated pairwise correlations, within each stage, between the top 300 maintained lineage-specific genes (Table S6 ). Gene pairs from the same lineage drastically increased their correlation in the transitioning from E4 to E5, and within EPI and PE gene sets, the correlations gradually increased from E5 to E7, whereas between figure) . The x axis indicates pseudo-time, as determined in Figure 1F . Each embryo was assigned a time using the mean of the cellular pseudo-times of the cells in that embryo. Each dot below the x axis indicates an embryo, colored by the embryonic day of sampling. (C) As (B) but with respect to EPI versus PE. (D) Gene-gene Pearson's correlation matrix using the top 100 lineage-specific genes from each lineage. Gene-modules were determined based on hierarchical clustering of the correlation matrix and labeled with representative genes being part of the cluster. (E) Heatmap of expression levels (RPKM) for E3-E5 cells using the top 100 lineage-specific genes from each lineage. Cell groups were ordered according to their pre-determined groups, indicated by the colored dendrogram, and clustered within their respective group (E3, E4, E5.early, E5.mid, and E5.late). E5.mid cells were classified into three sub-groups based on the observed hierarchical clusters (EPI, PE, and TE). Genes were grouped according to observed hierarchical clusters and named based on which type of cells, and at which time point, the genes were expressed. (F) RPKM mean expression levels of lineage-specific gene sub-clusters as identified in Figure 4D . Vertical lines indicate 95% non-parametric bootstrap confidence interval across cells (B = 1,000). (G) RPKM expression levels of representative genes from each gene sub-cluster. Vertical lines indicate 95% non-parametric bootstrap confidence interval across cells (B = 1,000). See also Figure S4 , Tables S5 and S6 , and Movie S1.
Cell 165 (legend continued on next page) TE-specific genes, the correlations decreased in E6 and E7, which may reflect the mural-polar polarization ( Figure S4C ).
Preimplantation Sex Differences
To investigate whether sex differences were already present during preimplantation development, we performed differential expression analysis between female and male cells within embryonic day and lineages. We identified 173 differentially expressed genes (FDR %5%), out of which 58 were autosomal (0.5% of expressed autosomal genes) (Figures S4E and S4F ; Table S7 ). As expected, SRY was not expressed in any cell, indicating that the sex-determination program had not yet initiated ( Figure S4G ). Thirteen differentially expressed Y chromosome genes were identified, of which nine had X-linked paralogs (Figure S4H) . Several of these X-Y paralogous gene pairs had high expression correlations ( Figure S4I ), suggesting conserved regulation. Strikingly, the X chromosome dominated the contribution of sex-biased genes, having 105 (27% of expressed X genes) significantly higher expressed in female cells but only 7 (1.8% of expressed X genes) higher in male cells, and intriguingly, there was a clear trend of gradual decrease of the female X chromosome overexpression from E4 to E7 ( Figure S4F ).
Dosage Compensation of the X Chromosome
The large number of female and male cells provided the opportunity to evaluate X chromosome expression dynamics throughout human preimplantation. Interestingly, we observed that specifically X chromosome genes tended to become downregulated with time. Spearman correlations between expression level and embryonic time were negative for most X-linked genes in female cells, but not in male cells ( Figure 5A ; p = 1.3eÀ7 female versus male, MWW) and not for autosomal genes (p > 0.05). To further study this female-specific downregulation of the X chromosome, we calculated female-to-male relative expression levels for transcribed genes at each embryonic day and cell lineage. This revealed that beyond the completion of ZGA at E4, a stage at which female cells have two active X chromosomes, X-linked genes became gradually dose compensated in all lineages (Figures 5B-5E; p = 4.7eÀ4 to 2.1eÀ34, MWW). This equilibration of female and male expression was not a result of transcriptional upregulation in males, since the total X chromosome output per cell remained nearly constant in males but distinctly dropped between E4 and E7 in females ( Figure 5F ; p = 6.8eÀ45, MWW). To investigate whether this dampening of female X chromosome expression occurred chromosomewide, the female-to-male expression was calculated by moving averages along the chromosome. This revealed a gradual and X chromosome-wide dosage compensation mechanism (Figure 5G) , with tendency of slightly delayed downregulation of regions around the centromere and the distal q-arm. As expected, autosomes, serving as negative controls, showed equivalent expression in male and female cells ( Figure 5G ). These data imply that X chromosome-wide dosage compensation takes place in all three cell lineages, initiating between E4 and E5 and reaching an overall $70%-85% compensation at E7. This is dependent on chromosomal region and whether expressionratios of individual genes ( Figures 5B-5E ) or the total X chromosome expression output ( Figure 5F ) is considered.
XIST and XACT Expression Interestingly, X chromosome dosage compensation coincided with an upregulation of XIST in female cells ( Figures 5H and 5I ). We also detected sporadic XIST expression in male cells, although at substantially ($15-fold) lower levels ( Figure 5H ; p = 3.1eÀ3 to 1.9eÀ50, MWW). Transcription of XACT, an X-linked lncRNA recently shown to cover XIST-free X chromosomes in cultured human embryonic stem cells (hESCs) (Vallot et al., 2015) , was activated at E4 in both sexes, but at significantly higher levels in females (Figures S5A and S5B; p = 2.2eÀ5, female versus male at E4). Moreover, XACT expression was reduced in TE cells already at E5, while its expression level was maintained slightly longer in EPI and PE cells.
Biallelic Expression of Dose-Compensated Genes
To investigate whether the observed dosage compensation process possessed hallmarks of XCI, we sought to investigate the X chromosome expression at an allelic resolution. Although parental allelic origin was not available, we could call the allelic expression for each single nucleotide variant (SNV) present in the Single Nucleotide Polymorphism Database (dbSNP) (Sherry et al., 2001 ) within each cell, as either undetected, biallelic, or monoallelic for the reference or alternative allele (Supplemental Experimental Procedures) . Surprisingly, the degree of biallelic X chromosome expression in female E7 cells was similar to that of female E4 cells, in which two X:es are active ( Figure 6A ; p > 0.05, female E4 versus E7, Fisher's exact test). The low frequency of biallelic X chromosome SNVs in male cells verified the accuracy in the allelic expression analysis ( Figure 6A ; p = 2.9eÀ49, male E7 versus female E7, Fisher's exact test). Furthermore, embryos carrying a SNP within the XIST gene showed that it was biallelically expressed throughout the progression of dosage compensation . Biallelic expression was also observed for individual X-linked genes that are normally subjected to conventional XCI in mature tissues, even at E7 ( Figure 6B ). To validate the SNP calls and biallelic expression of X chromosome genes in female E7 cells, we Sanger-sequenced SNP-containing sequences from the single-cell cDNA libraries, indeed confirming the allelic pattern of 36/36 tested samples or SNPs ( Figures S6A-S6D ).
Moving beyond single-gene analyses, we assessed whether the X chromosome as a whole progressed toward more monoallelic expression during female preimplantation development. To do this, we determined the fraction of biallelic and monoallelic expression for chromosome X, as well as for autosomes in each cell. Monoallelic detection using single-cell RNA-seq can appear both due to transcriptional bursting as well as from technical (H) XIST expression-level boxplots per sex, day and lineage. p values indicate significant differences between male and female expression distributions (two-sided MWW; ''ns'' denotes not significant).
(I) The fraction of cells with XIST RNA expression above indicated thresholds, stratified by sex and stage. See also Figure S5 and Table S7 . dropout of RNA molecules (Reinius and Sandberg, 2015) , but regulated monoallelic expression such as that of gradual XCI is readily detectable (Deng et al., 2014a) . Under a conventional model of XCI (i.e., a single X chromosome becoming inactivated), we therefore expected the fraction of biallelic detections from the X chromosome to steadily decrease between E4 and E7 in female cells. In contrast, we found that the X chromosome's biallelic fraction did not decrease as the dose equilibration progressed, but remained similar to that of autosomes ( Figure 6C ). This pattern contrasted markedly with the decreased biallelic fraction observed in mouse ( Figures S6E and S6F ), utilized as a positive control for validation of the approach, in which $60% X inactivation is reached by the early blastocyst stage. As control of completed conventional XCI in human, we analyzed single-cell RNA-seq libraries from primary pancreatic alpha cells, which displayed female-to-male dosage compensation of X chromosome-wide expression as expected ( Figure S6G ). As an additional control, we analyzed in vitro cultured human female fibroblasts. Both of these somatic cell types showed lowered rates of biallelic expression compared to female E7 preimplantation cells (p = 7.4eÀ5 and 2.5eÀ7, MWW; Figure 6C ), consistent with the inactivation of one X chromosome in the somatic cells, but not in E7 preimplantation cells.
Dual XIST Clouds with Biallelic Expression of ATRX We analyzed the localization and allelic expression pattern of XIST in female (n = 5) and male (n = 5) E7 embryos by strand-specific single-molecule RNA FISH. The majority of female cells (mean 83%) had dual XIST coats and an additional $6% of cells displayed biallelic expression with skewed coating (Figures 7A-7C) , and only $6% of cells had one XIST coat. In contrast, $11% of male cells had an XIST coat while $78% of the male cells were XIST-negative ( Figure 7C ). In parallel to XIST, we included RNA probes for the X-linked gene ATRX ( Figure 7D ), which is dosage compensated at E7 (female-to-male fold-change 1.08 at E7 p > 0.05; 2.01 at E4 p = 5.4eÀ8, MWW). Nascent-located dots indicated that ATRX was biallelically expressed in female cells with dual XIST coats ( Figure 7D ). To verify that ATRX was dosage compensated, we blindly counted single-molecule ATRX specks in female and male cells. This confirmed dosage compensation of ATRX at E7 (median 8 and 7 molecules per cell count area in female and male respectively, fold-change = 1.14, p > 0.05) (Figure 7E) . Altogether, our single-cell RNA-seq and RNA FISH data suggest that X chromosome dosage compensation in the human preimplantation embryo is accomplished by reducing the expression of both X chromosomes, in contrast to the complete silencing of one randomly selected X chromosome that occurs later in development.
DISCUSSION
We generated a transcriptional resource of human preimplantation development including 1,529 individual cells from 88 embryos. The inclusion of a large number of embryos per stage will dilute out embryo-specific differences that might arise due to embryo-specific genetic variation and abnormalities. Indeed, the analyses of the complete dataset revealed that cellular transcriptomes primarily segregated according to embryonic stage, followed by segregations into lineages (TE-ICM and EPI-PE), embryo-to-embryo variability and subpopulations (polar to mural TE).
Our analyses demonstrated that the segregation of all three lineages occurs simultaneously, given our temporal resolution, and coincides with blastocyst formation at E5. This is in contrast to the model developed from mouse studies where the TE and ICM fate is initiated in a positional and cell polarization-dependent manner within the morula (Cockburn and Rossant, 2010) , followed by a subsequent progressive maturation of EPI and PE that is driven by Fgf signaling in the blastocyst (Yamanaka et al., 2010) . As human morula compaction occurs at the 16-and not the 8-cell stage (Nikas et al., 1996) , a delay in lineage segregation is not entirely surprising and this observation is also in agreement with a previous paper showing CDX2 expression only in the expanded human blastocyst (Niakan and Eggan, 2013) . It should also be noted that human compaction is not as prominent as in the mouse, with partial compaction occurring in some blastomeres, further delaying the formation of distinct inner-outer compartments. In the late E4 compacting morula cells, a transcriptional TE program is initiated, including increased expression of GATA3, PTGES, and PDGFA. Importantly, this transcriptional induction occurs while simultaneously co-expressing EPI and PE genes. It is not until E5, during blastocyst formation, that these co-expressed lineage genes start to become mutually restrictive.
In addition to elucidating the dynamics of lineage specification, our analyses identified novel and less-studied genes that may be important for preimplantation development. For example ARGFX, ranked as the seventh most EPI-specific gene, is a (Figures S6A-S6D ). (C) Boxplots showing the proportion of biallelic expression from the X chromosome (chrX) relative to that of autosomes (fraction biallelic chrX SNVs / fraction biallelic autosomal SNVs), shown for female and male E4-E7. Human primary pancreatic alpha cells and in vitro female fibroblasts are included as a control reference, representing somatic cells with conventional XCI. Green dots indicate medians when performing the same analysis on individual autosomal chromosomes (shown for chr1-3). Cells with at least 25 detected chrX SNPs were considered. The panel above the boxplots, ''Expression-dose equivalent,'' indicates the female-to-male total X chromosome-wide expression dose (median ratio of total expression in Figures 5F and S6G ) for stages and cell types for which both female and male data were available (E4 to E7 and pancreatic cells), and the same for chr1-3. See also Figure S6 .
proposed homeobox gene where the coding region is disrupted in most mammalian genomes analyzed, with exception of human (Li and Holland, 2010) . LINC00261, the top ranked gene enriched in PE, was recently identified as a definitive endodermspecific lncRNA driving FOXA2 expression through recruitment of SMAD2/3 to its promoter (Jiang et al., 2015) . With LINC00261 and FOXA2 being ranked as number 1 and 34 among the PEspecific transcripts, it is reasonable to speculate that this lncRNA may be an important regulator of PE specification.
The extensive dataset we present here revealed that gradual dosage compensation of the X chromosome occurred in all three lineages during human preimplantation development with both X copies still being actively transcribed throughout this process. Further, the biallelic expression of XIST and other X-linked genes in E7 blastomeres are consistent with the patterns of nascent RNA stains previously obtained by RNA-FISH (Okamoto et al., 2011) although conclusions derived solely from the allelic patterns in these earlier studies may have led to an opposite stand regarding the occurrence of dose compensation. Studies on cultured human ESCs have generated rather divergent observations regarding their XCI status (Lessing et al., 2013) , and our data suggest that the human pluripotent ground-state should be characterized by female cells expressing XIST and having both X chromosomes active while still demonstrating female to male dosage compensation.
The issue of unequal sex-chromosome dose has both emerged and been resolved many times during evolution, using diverse strategies (Deng et al., 2014b; Mank, 2009 (E) Boxplots of E7 RNA-seq and RNA-FISH ATRX expression levels. RNA-FISH counts confirmed that the expression levels of ATRX in female and male were on par (mean 8.9 and 8.0; median 8 and 7, respectively), indicating dosage compensation at E7. mammalian taxa, there exists separate solutions to dosage compensation (Escamilla-Del-Arenal et al., 2011), and XIST is an exclusively eutherian invention. Intriguingly, the conventional XCI model where one of the two X chromosomes is inactivated, as demonstrated in the mouse (Mak et al., 2004; Okamoto et al., 2005) , does not satisfactorily explain the dynamics of X chromosome expression we observed in human preimplantation development. Instead, the data fit better with a model of an initially dual and partial expression dampening of the two X chromosomes. XIST represents an obvious candidate as a mediator for this dampening. However, the possibility that another system, conceivably the evolutionary traces of a more ancient dosage compensation mechanism, might act as a second layer of compensation in human preimplantation development should also be considered. Finally, the transcriptional atlas of the human preimplantation embryo we provide here has unprecedented cellular and temporal resolution and will therefore be a unique resource in future research aiming to better understand human development and embryonic stem cells.
EXPERIMENTAL PROCEDURES
Human embryos were obtained from two cohorts at the Huddinge Karolinska Hospital and Carl von Linné Clinic with ethical approval from regional ethics board (2012/1765-31/1). The first cohort was from preimplantation genetic diagnosis (PGD) testing on embryonic day (E) 4 and cultured until E7 (expanded blastocyst, just prior to implantation) under standard conditions as performed in the IVF Clinic (5% CO 2 /5% O 2 in CCM media (Vitrolife) covered with Ovoil (Vitrolife). The second cohort was from frozen E2 embryos thawed (ThawKit Cleave, VitroLife) and cultured in G-1 Plus media (VitroLife) and from E3 in CCM media. As we are restricted to embryos cultured in vitro, we cannot exclude potential differences with their in vivo counterparts. However, we anticipate these differences to be relatively subtle as in vitro cultured embryos used in infertility treatment progress and give rise to viable offspring.
Embryos were dissociated through trituration in TrypLE, (Life Technologies) and picked with fine glass capillaries. For a subset of E5-E7 embryos, ICM cells were enriched using immunosurgery (15 embryos). Cells were dispensed in lysis buffer, and cDNA libraries were generated using Smart-seq2 (Picelli et al., 2014) . Briefly, following cell lysis, PolyA(+) RNA was reverse transcribed using SuperScript II reverse transcriptase (Invitrogen) and nested primers, utilizing a strand-switch reaction to add a reverse primer for the second-strand synthesis. The cDNA was amplified by PCR (18 cycles) using KAPA HiFi HotStart ReadyMix (KAPA Biosystems) and purified using magnetic beads. The quantity and quality of the cDNA libraries were assessed using an Agilent 2100 BioAnalyzer (Agilent Technologies). cDNA ($1 ng) was tagmented using transposase Tn5 and amplified with a dual-index (i7 and i5; Illumina; 10 cycles) and individual Nextera XT libraries were purified with magnetic beads. Indexed sequence libraries were pooled for multiplexing ($40 samples per lane), and single-end sequencing was performed on HiSeq 2000 using TrueSeq dualindex sequencing primers (Illumina). For further details and data analysis see the Supplemental Experimental Procedures.
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(B) We further evaluated two SNPs located within the same gene (PDHA1) and PCR amplicon, for which one embryo had heterozygous expression at both SNPs and another embryo had heterozygous expression at only one of the two SNPs according to our single-cell RNA-seq data (allelic RNA-seq data for these embryos is shown in D). The Sanger sequencing confirmed this pattern.
(C) For one gene, TSPAN6, we additionally generated two separate amplicons for Sanger sequencing. Cells that had heterozygous expression for the two different SNPs located within these disjoint amplicons (according to the single-cell RNA-seq data, shown in D) were also confirmed to have heterozygous expression at both SNPs by Sanger sequencing.
(D) Allele-expression barplots (as in main Figure 6B ) shown for embryos from which single-cells were used for the double Sanger validations presented in (B) and (C). (E) Allele-level expression boxplots of mouse preimplantation cells from different stages, showing the paternal (C57BL/6J) / maternal (CAST/EiJ) expression ratio per cell on the y axis. This indicates that paternal X chromosome inactivation reached $60% completion at the mouse early blastocyst stage. The plots in (E) represent a re-analysis of our previously reported data (Deng et. al, 2014a) , but using the same threshold for calling monoallelic expression as used in the current study (Supplemental Experimental Procedures). 
Supplemental Experimental Procedures
Immunosurgery For immunosurgery, 1 droplet (30µl) of anti-human antibody (1:3 dilution, Sigma-Aldrich H8765) was aliquoted per embryo onto pre-warmed plastic dishes. Zona pellucidae were removed with Tyrode's solution (SigmaAldrich) and placed into droplet for at least one hour in incubator. Embryos were then washed 3x with KSOM medium (Millipore) and subsequently placed into a droplet containing complement guinea pig sera (SigmaAldrich; S1639) for 15 mins. Thereafter, embryos were placed into another droplet of KSOM medium and returned to the incubator for 30 mins-1 hour and periodically triturated to isolate the ICM. Once the ICM had been isolated, it was processed as described above.
Fibroblasts
Commercially available normal human dermal fibroblasts (CC-2511, Lonza) generated from a Caucasian female (31 years old) were utilized as a control for the X-dosage compensation analysis. Cells were cultured (DMEM, 10% FBS, 50U/ml 50mg/ml penicillin-streptomycin; Life Technologies) until passage 12, at which time they were picked and processed as described in the main text for embryo cells.
Immunostaining
Embryos were fixed (4% formaldehyde) immediately upon removal from incubator, permeabilized (0.3% Triton-X-100 in PBS) and then blocked with blocking solution (0.1% Tween20 and 4% FBS (10082-147; ThermoFisher) in PBS) for 4 hours at room temperature. Embryos were then incubated in primary antibody overnight at 4°C, followed by 3x5 mins washes in blocking solution and placed in secondary antibody, AlexaFluor 555 donkey anti-rabbit (1:1000 in blocking solution; A31572; LifeTechnologies) for 2hrs, followed by Hoechst 33342 (1µg/ml; LifeTechnologies) nuclear stain for 20 mins at room temperature. All incubations and washes were carried out in a clean well using 4 well plates (734-2176, VWR). Embryos were mounted on a SuperFrost/Plus slide with spacers filled with 17µl of PBS. Embryos were imaged on an Andor spinning disk confocal microscope with 20x dry objective, using an Andor EM-CCD camera. Z-stack images where then processed using IMARIS (Bitplane) and ImageJ (http://imagej.nih.gov/ij/).
RNA FISH
E7 embryos were fixed with 4% formaldehyde (Polysciences) for 15 mins at room temperature, followed by a wash with PBS. Fixed embryos were placed on a silanized glass coverslip and dried for approximately 2 mins. Coverslip with embryos was placed in pre-chilled (-20°C) methanol (Sigma) for 10 mins at -20°C to permeabilize cells, and allowed to air dry for 30 mins at room temperature. Dried samples were then heat shocked with TE buffer, pH 8.0 (Promega) at 70°C for 10 mins and washed with 2X SSC (ThermoFisher Scientific). Samples were hybridized for 6h at 38.5°C in a humidity chamber with XIST Quasar 570 (125 nM; SMF-2038-1; BioSearch Technologies) and ATRX Quasar 670 (125 nM; VSMF-2019-5; BioSearch Technologies) in hybridization buffer comprising of RNase free water, 2X SSC, 10% w/v dextran sulfate (Sigma), 10% formamide (ThermoFisher Scientific), 2 mg/ml E. coli tRNA (Sigma), 2 mM ribonucleoside vanadyl complex (New England Biolabs), and 2 mg/ml bovine serum albumin (Jackson ImmunoResearch). Following hybridization, samples were washed with 20% formamide in 2X SSC for 4x15 mins at 38.5°C. During the last 15 mins wash, Hoescht 33342 (1µg/ml; ThermoFisher Scientific) was added to the wash buffer. Samples were then washed with 2X SSC and mounted with Prolong Diamond antifade (ThermoFisher Scientific) and allowed to dry 24 h in the dark at room temperature before imaging.
DNA FISH
Following RNA FISH, the coverslip with embryos was recovered by 15 mins incubation in PBS at 37°C, and washed in PBS for 5 mins. Samples were then re-fixed with 4% formaldehyde, 0.5% Tergitol (Sigma) and 0.5% Triton X-100 (Sigma) for 10 mins at room temperature, followed by a PBS wash and then incubated for 30 mins at 37°C with 2 mg/ml RNase A (Qiagen). Following a PBS wash, samples were treated with 0.5% Triton X-100 in 0.2 N HCl for 10 mins on ice and denatured in 70% formamide in 2X SSC at 73°C for 7 mins. Following denaturation, samples were immediately placed in chilled 70% Ethanol on ice for 2 mins, followed by 80% and 100% ethanol (2 mins each). Hybridization mix of Vysis CEP Y (DYZ1) Spectrum Orange (05J08-024; AbbottMolecular) and Vysis CEP X (DXZ1) Spectrum Green (05J10-023; AbbottMolecular) in CEP hybridization buffer was denatured in 73°C for 5 mins and applied to samples for 16h at 42°C in a humidity chamber. Following hybridization, samples were washed with 50% formamide in 2X SSC for 2x5 mins, and 2X SSC for 2x5 mins at 46°C. Samples were then stained for Hoescht 33342 (1µg/ml) for 15 mins at room temperature and subsequently washed in 2X SSC. Prolong Diamond antifade mounting media was used and allowed to dry for 24h in the dark at room temperature before imaging.
Imaging
Samples were imaged using Nikon Eclipse Ti-E inverted microscope with 60X 1.4 NA oil-immersion objective, Nikon Intensilight mercury-fiber illuminator, and Andor Zyla 5.5 camera, with 0.3µm z-stack step size.
FISH Image Processing and Analysis
The acquired images where first converted to numpy arrays using the nd2reader python library (Jim, 2015) and then processed with a previously described (Zeisel et al., 2015) custom python script relying on the numpy, scipy.ndimage (Jones et al., 2015) and scikit-image (van der Walt et al., 2014) libraries. Briefly, after background removal using a large kernel gaussian filter, a Laplacian-of-Gaussian was used to enhance the RNA dots. The images were then stitched with Fiji's grid/collection stitching plugin using the nuclei staining as reference (Preibisch et al., 2009) . For the ATRX quantification, RNA dots were counted blindly with respect to embryonic sex, and to avoid counting RNA specks from potentially overlapping soma only signals within the nuclear perimeter were considered.
Experimental Confirmation of SNPs and Biallelic Expression by Sanger Sequencing
For each SNP confirmation, 2ul of Smart-seq2 cDNA library from a single female E7 cell was used as template, and an amplicon incorporating the SNP of interest was amplified by PCR using KAPA HiFi HotStart ReadyMix (KAPA Biosystems) and the following thermal cycle: 98°C (3 mins), followed by 22 cycles of 98°C (20s), 59°C (15s), 72°C (30s), and a final elongation step 72°C (5 mins). After amplification, the PCR products were purified using Ampure XP beads (Beckman Coulter) at the volume ratio 1:1. The fragment size and yield of product for each cell and amplicon were inspected on an Agilent 2100 Bioanalyzer (Agilent Technologies), and products of confirmed correct size were Sanger sequenced (LIGHTrun, GATC Biotech AG Germany). ApE v2.0.49 (M. Wayne Davis) was used for the sequence alignments. The following primers (5' to 3') were used for the PCRs as well as in the Sanger reactions: HUWE1 ( 
Single-Cell RNA-Seq Data Pre-Processing and Quality Control
Reads were mapped to the human genome (hg19) using STAR with default settings (Dobin et al., 2013) and only uniquely mapped reads were kept. Gene expression levels (RefSeq annotations) were estimated in terms of reads per kilobase exon model and per million mapped reads (RPKM) using rpkmforgenes (Ramsköld et al., 2009) . Read counts from regions where different RefSeq genes overlapped were excluded. Genes were filtered, keeping 15,633 out of 26,178 genes that were expressed in at least 5 out of 1,919 sequenced cells (RPKM ≥ 10) and for which cells with expression came from at least two different embryos. Cells were quality-filtered based on four criteria, leaving 1,529 cells post-filtering out of 1,919 sequenced cells. First, Spearman correlations, using the RPKM expression levels of all genes, for every possible pair of cells were calculated and a histogram of the maximum correlation obtained for each cell, corresponding to the most similar cell, was used to identify 305 outlier cells with a maximum pair-wise correlations below 0.63 ( Figure 1A ). Second, a histogram of the number of expressed genes per cell was used to identify 330 outlier cells with less than 5000 expressed genes ( Figure  1B ). Third, a histogram of the total transcriptional expression output from the sex chromosomes (RPKM sum) was used to identify 33 cells with indeterminable sex, or a called sex that was inconsistent with other cells of that embryo (see Figure S1 and section "Calling Embryonic Sex", below). Fourth, 13 outlier cells were identified using PCA and t-SNE dimensionality reduction.
Gene Variability and Temporal Separation of Cells
A gene-variability statistic was calculated that adjusted for the mean-variance relationship present in single-cell RNA-seq data ( Figure S2A ). This was done by assuming that the expression distribution of a gene follow a negative binomial for which the variance depends on the mean, v = m + m 2 /r, where r is the overdispersion, implying that cv 2 = v/m 2 = 1/m + 1/r. To estimate the technical variability we fitted such a model to our ERCC spike-in read counts and a gene-variability statistic was then obtained by adjusting for the technical variability present when conditioning on the mean expression level (Brennecke et al., 2013) . To stabilize the estimate we performed winsorization of the expression distribution of each gene, setting the most extreme value to the expression of the second most extreme cell. To tune the number of variable genes used, we plotted the genevariability statistic versus gene rank ( Figure S2B ) and performed grid-searches, including 100, 250, 500 and 1000 of the most variable genes, and visually assessed clusters obtained. Temporal separation of cells was obtained by applying dimensionality reducing techniques, including principal component analysis (PCA), student-t stochastic neighbor embedding (t-SNE; van der Maaten and Hinton, 2008) and diffusion maps (Haghverdi et al., 2015) , to all cells using the most variable genes (Figure S2C-D) . Cells were assigned a pseudo-time by fitting a principal curve (Hastier and Stuetzle, 1989) to all cells within the subspace spanned by the first two t-SNE dimensions, excluding ICM cells, as to not let lineage segregation affect the temporal principal curve fit ( Figure 1F ). Subsequently, cells were orthogonally projected onto the fitted principal curve and its unit-speed arc-length parameterization was used as pseudo-time.
Lineage Segregation of Cells
Cells were stratified by embryonic day that they were picked and within each such stratum a PCA was performed. Cells were colored by their expression of previously known lineage markers using a weighted mean, where expression levels of marker genes of one lineage were assigned a weight of 1 and genes of the other lineage a weight of -1 ( Figure 2B, 2D and S3 ). Principal components of interest were identified by both observing a separation of the cells' marker coloring as well as that genes identified to be relevant for lineage separation were found to have high PCA loadings. We adjusted for embryo-wise batch effects in cases where cells were primarily clustering by embryo using COMBAT (Johnson et al., 2007) . With respect to E5 cells we observed a subset of cells that were placed prior to a sharp increase in spread in a t-SNE plot of all cells ( Figure  2A) , and we used a pseudo-time cutoff of ≤ 12.5 (mean pseudo-time per embryo) to indicate such early E5 embryos. Furthermore, these cells were in the middle with respect to PC1, which we identified as the E5 TE-ICM principal component; therefore they were assigned as pre-lineage ( Figure 2B ). Likewise, a second subset of E5 cells were also assigned as pre-lineage as they were in the middle of the ICM-TE principal component (PC1) and they also formed a middle cluster that exhibited co-expression of ICM and TE genes when performing hierarchical clustering using E5 ICM and TE genes obtained from differential expression analysis ( Figure 2C ), as described in the next section.
Lineage Differential Expression Analysis
Within each of the three stages, E5-E7, every pair-wise combination of lineage groups, among the three groups of cells corresponding to lineage, EPI, PE and TE, was subjected to single cell differential expression analysis using SCDE and adjusting for sex by supplying it as a co-variate (Kharchenko et al., 2014) (Table S1 ). Twosided p-values were calculated from the Benjamini-Hochberg multiple testing corrected Z-score (cZ) using the normal distribution as null hypothesis, and a significance level of 0.05 was used to deem genes as significantly differentially expressed. Lineage-specific p-values were obtained by combining the SCDE cZ-scores for the two corresponding pair-wise comparisons using Stouffer's method. For example, EPI-specific p-values for each gene were derived by combining the two cZ-scores from the EPI vs. PE and EPI vs. TE comparisons. To derive pvalues reflecting the tendency for a gene to maintain its lineage-specificity we combined the three lineagespecific p-values from each of the stages, E5-E7, using Stouffer's method (Table S1 and S2). Agglomerative hierarchical clustering using differentially expressed genes as input ( Figure 2C , 2E, 4E and S3) was conducted on log10-transformed RPKM expression-values, adding a pseudo-count of 1e-10, and employing Pearson correlation as distance measure between gene-pairs and between cell-pairs and using complete linkage as distance measure between clusters. Genes and cells with constant variance were removed prior to hierarchical clustering. Gene Ontology (GO) gene set enrichment analysis with the top 100 maintained lineage-specific differentially expressed genes from each of the three lineages as input was done using a hypergeometric test and Benjamini-Hochberg multiple testing adjustment ( Figure 3C and Table S3 ). GO terms were retrieved from a local mirror of the GO database.
Lineage Sub-population Analysis
To investigate if there were any subpopulations within the lineages we stratified the cells by embryonic day and lineage, resulting in 9 strata ({E5-E7} x {EPI, PE, TE}), and calculated the most variable genes within each such stratum, accounting for the mean-variance relationship as described above. For each stratum we used the top 250 most variable genes and found that the strongest remaining factor was embryo-to-embryo differences, since cells clearly tended to cluster by embryo, both when using agglomerative hierarchical and when looking at the first two principal components of a PCA plot. We therefore adjusted for embryo effects within each stratum, by supplying embryo as a batch factor to the program Combat (R package "sva") and subsequently retrieved the most variable genes of the embryo-adjusted data within each stratum. We used the top 250 most variable genes, and performed PAM clustering in the PCA dimensionality reduced space ( Figure 3D ). Once cells had been classified we conducted differential expression analysis between the two groups, separately in E6 and E7, using SCDE, and p-values from E6 and E7 were combined using Stouffer's method (Table S4) . Gene Ontology gene set enrichment analysis was subsequently done on the intersection of genes being significantly upregulated in both E6 and E7 in the class denoted as "polar" using genes expressed in all E6 and E7 TE cells as background (7458 genes, mean RPKM ≥ 5 across all cells and RPKM ≥5 in ≥10% of E6 and E7 TE cells).
Developmental Progression Analysis
To assess temporal differences we conducted differential gene expression analysis between each embryonic day, and between time-points within the same lineage using SCDE ( Figure S4A and Table S5 ). To obtain a view of the complete dataset with respect to lineage segregation and developmental time we applied a diffusion map to all cells using E5 lineage-specific genes derived from the differential expression analysis between lineages described above ( Figure 4A and Movie S1). As an alternative approach to obtain a simultaneous view of the lineage segregation and developmental time we plotted the degree of lineage-specificity of each cell versus its embryonic pseudo-time ( Figure 4B and 4C) . To determine the degree of lineage-specificity of cells we projected all cells to the two diffusion map components where a clear segregation with respect to lineage was observed. Subsequently, we trained a support vector machine (SVM) to find a decision surface that optimally separated the lineages within the subspace of these two lineage-related diffusion map components. The lineage-specificity of each cell was then calculated as a cell's orthogonal distance to the SVM lineage decision surface. Embryonic pseudo-time was calculated as the mean of the cellular pseudo-times of the cells belonging to an embryo. Classification of E5 cells into temporal sub-groups was done using top 300 maintained lineage-specific genes (100 genes from each lineage) and by identifying hierarchical sub-clusters corresponding to specific expression patterns ( Figure 4E ). Genes were grouped by hierarchical clustering using Pearson's correlation as distance between genes ( Figure 4D and 4E) . To assess expression variability of genes within embryos and how that variability changed over time ( Figure S4B ), we first calculated a variability score adjusted for the mean-variance dependency present in single-cell RNA-seq data by calculating the ratio between the squared coefficient of variation (CV 2 ) for a gene, with respect to the expression distribution within an embryo, and the predicted technical CV 2 obtained from the ERCC spike-in expression levels, as described above. As expression level input we used read counts normalized with respect to the size-factor of each expression library (Love et al., 2014) , and for which winsorization of the most extreme expression levels to that of the second most extreme cell, among all 1,529 cells, was done. To avoid a dependency on the number of cells per embryo, we performed quantile normalization between the embryos with respect to each embryo's distribution of such obtained gene-wise variability ratios. To approximately order genes by the time that their expression variability reached a certain level, we performed local linear regression using a 1 st degree polynomial and using number of nearest neighbors (NN) as smoothing parameter, since the time-sampling of the embryos was not evenly spaced (R package locfit). Optimal NN was determined by a grid-search tuning of the NN, in the range 0.5 to 1, in steps of 0.01, choosing the model with the smallest Akaike Information Criterion. We timed all maintained lineage genes by the first time-point that a gene's local regression curve reached a particular variability score threshold. The threshold was chosen as 0.83, corresponding to the 90th percentile with respect to the variability score among all RefSeq genes. To assess gene-gene correlation patterns ( Figure S4C -D and Table S6 ) we calculated Pearson's correlation coefficients for RPKM expression levels between all possible pairs of maintained lineage genes. RPKMs were winsorized to stabilize against the most extreme value, censored to 1 RPKM to avoid possible random correlations, and log10-transformed.
Inference of Embryonic Sex
To determine the sex of each cell and embryo, we used the expression of Y-linked genes as indicator of sex. Cells with a chromosome-Y (chrY) RPKM sum (∑RPKM chrY ) >100 were classified as male and cells with ∑ RPKM chrY <50 were classified as female. Cells with 50<∑RPKM chrY <100 were excluded form the analyses. This segregated the embryos into two distinct groups ( Figure S1A) , with a mean ∑RPKM chrY of 605 for maleclassified cells and 1.0 for female-classified cells. For E3 cells we used a criterion, modified to be somewhat less strict, ∑RPKM chrY >100 in at least 50% of the cells of an embryo, to classify the whole embryo as male. The reasoning behind this special criterion in E3 was that the activation chrY genes was apparently incomplete in E3 (mean ∑RPKM chrY = 181, standard deviation 97 for male E3 cells and 636, standard deviation 182 for male E4-E7 cells) -in line with the notion of incomplete ZGA at E3. Cells that could not be sex-determined, or cells with a classified sex that was in conflict with other cells in an embryo, were excluded from further analysis (33 cells, 2.2%). For the X-chromosome analyses, we also excluded one female embryo (E5.early.31) that showed signs of an X0 karyotype, i.e. Turner syndome ( Figure S1E and Figure S1G ). For the analyses of XIST, XACT, and allelic expression, we also excluded a single male embryo (E6.15), as biallelic expression of many X-linked genes was detected in all cells of this particular male-classified embryo (something that we did not observe in any other male embryo).
Sex Differential Expression Analysis
To contrast cells of male and female sex, we performed differential expression analysis using SCDE within each stage and lineage (Table S7) . P-values were calculated as described above and a significance level cutoff of 0.05 was used to deem a gene significantly differentially expressed ( Figure S4E ). To assess the sex differences over time we also calculated the number of genes with an absolute fold-change ≥ 2 within each embryonic day (E4-E7) ( Figure S4F ). To avoid any possible dependency on the number of cells per stage we bootstrap resampled the number of cells down to 100 cells within each sex and stage. To investigate chromosome X-Y paralogous gene-pairs we selected such genes (Navarro-Costa, 2012) among significantly differentially expressed genes ( Figure S4H ) and calculated the correlation between mean male stage-wise expression levels using censored (RPKM ≥ 1) and log10-tranformed RPKM expression values ( Figure S4I ).
Zygotic Genome Activation and Maternal RNA Clearance
Total chrY expression per cell, shown in Figure 1C , was calculated as: ∑(RPKM gene i / µ (1/2) gene i, Male E4-E7 ) ubiquitous in which RPKM gene i denotes the expression level (RPKM) of a chrY gene "i" in a cell, µ (1/2) gene i, Male E4-E7 denotes the median RPKM for gene "i" over all male E4-E7 cells. The sum, ∑(x) ubiquitous, was calculated over broadly expressed chrY genes (DDX3Y, EIF1AY, KDM5D, PRKY, RPS4Y1, UTY and ZFY) , and the inclusion of all chrY genes gave similar results in this analysis. The fraction of chrX SNVs with biallelic calls (Fbi chrX ), used as indicator for the presence of maternal RNA in male (XY) embryos was determined as described in the section "Analyses of Allelic Expression" below. Cells with at least 25 informative SNPs on chrX were used in this analysis.
X-chromosome Expression
The distributions of Spearman correlations shown in Figure 5A were calculated using genes with mean RPKM (µ RPKM )>5 within each sex using cells from E4 to E7. The gene-wise female-to-male fold-changes shown in Figure 5B -E were calculated as the ratio µ RPKM, female cells / µ RPKM, male cells , including genes with µ RPKM, female & male >5 over the cells of the given embryonic day and lineage. The moving average of female to male relative expression shown in Figure 5G was calculated using a sliding window of 25 genes, and the ratio µ (1/2)RPKM, female cells / µ (1/2)RPKM, male cells , stratified on stage, in which µ (1/2)RPKM denotes median RPKM. Other window sizes gave similar results. Genes with µ (1/2)RPKM >5 in each of the sexes were included in this analysis. XACT RPKM ( Figure  S5A ) was calculated using reads aligning to the region chrX: 112, 983, 235 ,148, at which we observed a distinct peak of mapped reads above the background levels ( Figure S5B ). The RPKM sums for chrX shown in Figure 5F were calculated per cell using genes with 5<µ RPKM <200 calculated over all cells and embryonic days (the upper threshold was applied to prevent the weight of a few very high-expressed genes to dominate the estimate). The RPKM sums for human pancreatic alpha cells (Smart-seq2 single-cell RNA-seq data from Athanasia Palasantza and Dr Åsa Segerstolpe (Rickard Sandberg's lab), kindly shared before official data release) were calculated in the same way, but using genes with 5<µ RPKM <200 across pancreatic cells rather than embryonic cells.
Analyses of Allelic Expression
We used SAMtools mpileup (v. 1.2) to retrieve allelic read counts for SNVs available in dbSNP (build 142). Somatic SNVs were excluded (dbSNP flag SAO) and only validated SNVs were included (dbSNP flag VLD; 2+ minor allele count based on frequency or genotype data). Intergenic SNVs were excluded using Annovar (Wang et al., 2010) retaining SNVs within RefSeq genes. dbSNP genomic coordinates were liftover from hg38 to hg19 using the UCSC liftOver command line utility. SNVs identified within XIST ( Figure 6B ) were located in a region where XIST and TSIX overlap. To rule out the possibility that TSIX might have caused a false biallelic detection of XIST, we estimated TSIX's contribution to this signal using corresponding TSIX-and XIST-specific regions ( Figure S6C-E) . This analysis showed that TSIX was unlikely to cause the detected biallelic expression as the number of aligned reads to TSIX-specific regions were not above background levels (e.g. XIST expression was 431-fold higher than TSIX expression in female E7 cells; Figure S6D ). The lack of reads mapping to TSIXspecific regions in exon-intron overlapping segments was also apparent when visualizing the aligned reads using the IGV Genome browser (Broad Institute) ( Figure S6C ). For calling allelic expression (as either undetected, biallelic, or monoallelic with respect to the reference or alternative allele), we required at least three reads to call an SNV locus expressed, and an allele-specific expression bias of at least 10-fold to call an SNV locus monoallelic. The reasoning behind using the 10-fold criterion, rather than a 50-fold difference used in an earlier study of allelic expression (Deng et al., 2014a) , was to attain higher sensitivity to detect allele-biased states. With either criterion we observed that the rate of biallelic chrX expression in human female E4-E7 cells was similar to that of autosomes. For comparability, the plots of allelic expression in mouse, shown in Figure S6E -F, were based on the same criteria as for the human allelic analyses. The biallelic ratios shown in Figure 6C and Figure S6F were calculated as Fbi chrX / Fbi autosomes , in which Fbi denotes the fraction of SNVs with biallelic calls (biallelic calls / (biallelic calls + monoallelic calls)) in each cell. Cells with at least 25 SNP calls (bi-or monoallelic) on chrX were considered in Figure 6C as to only include cells with reliable estimates of the fraction of biallelic calls, and stricter or looser criteria for cell inclusion (e.g. minimum 40 or 20 allelic SNP calls) provided similar results. The same calculations were performed for chr1-3 ( Figure 6C ).
